ARLZ Archives - Blue Horseshoe Stocks

Blue Horseshoe Stocks: EGN Update & More

Energen Corp. EGN

A longer-term set of ideas we recently formulated were the EGN 09/21 $75 & 77.50 Calls. from our report on Monday morning. The contracts had shown marginal increases that day, but since then have added considerably to the highs we’ve observed.

We witnessed the following intraweek moves in these solid contracts, and with plenty of time left before expiration, even more gains are not out of the question.

The $75 Calls have thus far gone from 1.10-3.80 (+245%), while the $77.50′s have traded from .93-2.50 (+169%).
__________

Fresh Options Idea:
JWN Weekly $52.50-57.50 Calls

Extended Watchlist:
IZEA, FRO, GEMP, ARLZ, YUMA, ZOES, GST, EOLS

Blue Horseshoe Stocks: Recent Winners

Recapping Recent Hot Picks

First thing’s first- we would like to include a quick update on two of the stocks to appear in our report yesterday, in which we had already witnessed very nice gains. Both stock pressed to new highs during yesterday’s session, so we wanted to update readers on their continued success.

Tandem Diabetes Corp. TNDM – We called TNDM initially on April 11th, whereupon we observed a low of 6.62. Yesterday the stock rose another 12% intraday, running from 10.75 to 12.05. That new high represents an 82% jump since our first alert, just over a month ago.

Stein Mart, Inc. SMRT – Also appearing in yesterday’s report for having put up impressive figures following our March 16th alert and subsequent observed low of 1.33, was SMRT. The stock reached a notable new high of 3.94. marking a two-month uptrend amounting to 196%

Arcadia Biosciences, Inc. RKDA

To come back to yet another great call we made last Tuesday (05/08), we’ve got RKDA. A couple of sessions following that first call, the stock would register a low of 7.31, and this week, we’re seeing the stock reaching new heights.

Yesterday it hit 12.25, which marks a rise of 67% in a matter of just six trading days. There is still a lot of room to the upside on the chart for RKDA to travel, so we’re definitely going to keep our eyes peeled for further bullish activity from RKDA.

—

Heat Biologics, Inc. HTBX

Speaking of charts with potential, we tagged HTBX on Monday, and it has been trending in the right direction, trading up from 1.35 to 1.74 so far. As you can see on the provided snapshot, it still has a very ripe-looking chart.

Extended Watchlist:
ARLZ, BLNK, BOOT, HEAR, M

Blue Horseshoe Stocks: Bottom-Plays, Options & More

Celadon Group, Inc. CGI

We’ve been seeing a fair bit of bottom-bouncers running across our desks this week, and CGI is the latest to grab our attention. What we’ve got here is a very enticing chart with just about everything we look for in a potential bottom play.

The stock is beginning to come off of being massively oversold, has set higher lows and higher highs for each of the last three sessions, and has a sizable gap to fill to the upside. We also have a MACD that appears as if a bullish cross could be forthcoming, so we’ll definitely want to keep an eye on CGI this week.

____

Two other stocks on our bottom watchlist, California Resources Corp. and CRC Uni-Pixel, Inc. UNXL will remain there. We signaled these two just yesterday, and despite recording only marginal gains on the day, we still want to leave them a spot on our radar as well.

Valeant Pharmaceuticals, Inc. VRX – Options Idea

Speaking of bottom-bouncers, VRX recently rebounded off of new 52-week lows, and is hitting our scanners this morning. With a pleasing Q1 earnings call which included solid boosts in profits for the quarter as well as reinforced guidance for the remainder of the year, VRX is gapping up considerably in the premarket.

We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.

Extended Watchlist:
AMRS, ARLZ, CLNT, MTBC, XXII, ORRV(News)

Blue Horseshoe Stocks: JNUG Recap & Much More

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG) – Recap

Despite only providing a fleeting opportunity for gains on Tuesday morning after we submitted our options trading idea for the JNUG chain, we followed up with a reminder in yesterday’s report that the idea was still in play, and that we’d need to keep our heads on a swivel looking out for the move we were hoping for.

With the help of a Fed rate hike of a quarter of a percentage point, announced by Chairperson Janet Yellen yesterday, our specified contracts, the JNUG 03/31 $7-8 Calls took a serious turn for the better.

The daily ranges and potential profits were as follows:

$7 Calls – Range: .40-1.40 – Max Gain: 250%
$7.50 Calls – Range: .35-1.00 – Max Gain: 186%
$8 Calls – Range: .20-.87 – Max Gain: 335%

Once again, we’re going to reiterate our interest in these ideas, which could be in line to extend their highs, with JNUG gapping up in early trading this morning.

Aralez Pharmaceuticals, Inc. ARLZ

We placed ARLZ on bottom watch yesterday morning in what turned out to be a fantastic stroke of good timing. We just wanted to update readers this morning on the reversal which did indeed occur during the session. While the intraday gain potential topped out at 25% as the stock ran from the open (and also low of day) at 2.11 to as much as 2.63.

The inverted hammer candle that the stock posted yesterday is often thought to be an indicator of the end of a downward pattern, so we’ll be very interested to continue tracking ARLZ in sessions to come. Chart indicators are still looking very ripe, and we’d be surprised if the show was over after just a 25% rise.

Cannabis Sector Comments

Lastly, we just want to address the cannabis sector, particularly those stocks that are connected to legal recreational marijuana. After some very damaging comments made recently by the Trump Administration wherein it was suggested that the government could crack down on legal weed, yesterday we witnessed something of a reversal from Jeff Sessions.

Sessions appeared to hint at insufficient DOJ funding as a primary reason that perhaps the current regime will not be changing Obama-era guidance on leaving the treatment of recreational weed as a states’ rights issue.

On the heels of this development, we’re going to want to keep closer tabs on the cannabis sector once again, particularly those plays that lost a lot of ground after the first round of comments from Washington.

Some of our go-to favorites in the space have been OWCP, TRTC, SING, SGDH, CBIS, and MJNA, so we’ll be tracking these more closely in the days and weeks ahead, along with the sector as a whole, as stated above.

Fresh Options Idea:

The TSLA chart is looking ripe for a recovery, and the stock is gapping up moderately in premarket trading this morning. We want to signal a range of calls to monitor in the TSLA chain to potentially take advantage of what could be a protracted recovery. We’re going to zero in on the TSLA 04/07 $270-277.50 Calls, and monitor them in the days and weeks ahead.

Extended Watchlist:
NAK, ZSAN, ORCL, TPLM, PLX, RXII, IDRA

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Potential Rebound Plays

U.S. Stem Cell, Inc. USRM -We caught USRM for some nice gain opportunities a couple of weeks back. We had initially begun tracking this play after mentioning it on the morning of February 27th. Subsequent to that, we had witnessed an impressive run from a low of .014 to .0545, for a 289% gain in a span of just two sessions.

That was followed by an expected period of consolidation, but it appears as if USRM has found support at .0175. We’re going to want to return to monitoring this play more closely on the chance that it could be gearing up for another run. If it produced a move even a fraction of what we saw before, it will be worth its slot on our watchscreens.

______

Iconic Brands, Inc. ICNB – Speaking of familiar plays that could be in line for a rebound in upcoming sessions, we want to swing back around to ICNB this week. We had tracked this one to some decent gains after tagging it for observation on January 24th. Following that, the stock would trade in a range from .018 up to .0339, a respectable move of 88%

But like the above-mentioned stock, after its run, it basically underwent a big-time consolidation which lasted nearly a whole month. That brings us up to yesterday, when we noticed ICNB giving off something of a rebound signal. We’ll go back to watching more closely in the next few sessions.

Aralez Pharmaceuticals, Inc. ARLZ – Bottom Watcher

ARLZ has been falling off a cliff this week, and despite the fact that it may yet have further to fall, we’re going to want to begin monitoring it as it attempts to sniff out a solid support level. There could definitely be some opportunities waiting for traders that can properly time the recovery.

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG) – Reminder

Apart from some quick chances for early gains yesterday, our freshly formulated options idea for JNUG may need some time to mature. That’s why we chose an expiration date a couple of weeks out. We’ll continue to have the JNUG 03/31 $7-8 Calls on our radars moving forward.

Extended Watchlist:
DTII, AVXL, AXAS, OWCP, SPCL, IMMU, CVRS